Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer

Overview of attention for article published in JAMA Oncology, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Dimensions has found 12 publications that cite this research output.

Article in The Prostate (June 2022)

Article in World Journal of Clinical Cases (April 2022)

Article in Frontiers in Oncology (August 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.